Health Practitioner Regulation National Law (NSW) Health Practitioner Regulation (New South Wales) Amendment (Partner Treatment-Chlamydia) Regulation 2016 (NSW)

New South Wales

Health Practitioner Regulation (New South

Wales) Amendment (Partner Treatment—

Chlamydia) Regulation 2016

under the

Health Practitioner Regulation National Law (NSW)

His Excellency the Governor, with the advice of the Executive Council, has made the following

Regulation under the Health Practitioner Regulation National Law (NSW).

JILLIAN SKINNER, MP

Minister for Health

Explanatory note
The object of this Regulation is to allow the name and email address or mobile phone number of a patient’s partner to be sufficient information to identify the partner on a record kept by the medical practitioner or medical corporation if the medical treatment includes prescribing or supplying azithromycin for the partner for the treatment of chlamydia.

This Regulation is made under the Health Practitioner Regulation National Law (NSW), including section 247A (the NSW regulation-making power).

Health Practitioner Regulation (New South Wales) Amendment (Partner Treatment—Chlamydia) Regulation

2016 [NSW]

Health Practitioner Regulation (New South Wales) Amendment

(Partner Treatment—Chlamydia) Regulation 2016

under the

Health Practitioner Regulation National Law (NSW)

1      Name of Regulation

This Regulation is the Health Practitioner Regulation (New South Wales)
Amendment (Partner Treatment—Chlamydia) Regulation 2016.

2      Commencement

This Regulation commences on the day on which it is published on the NSW legislation website.

3 Amendment of Health Practitioner Regulation (New South Wales) Regulation 2010

Schedule 2 Records kept by medical practitioners and medical corporations in relation to patients

Insert after clause 1:

1A

Record of partners of patients being treated for chlamydia

(1)

A reference in this Schedule and clause 7 (1) of this Regulation to a patient includes a reference to a partner of the patient if the patient is being treated for chlamydia and that treatment includes the patient and the partner being prescribed or supplied azithromycin for the treatment of chlamydia. For that purpose, the name and email address or mobile phone number of the partner is sufficient information to identify the partner.

(2)

In this clause: partner of a patient includes any of the following:

(a)	the patient’s spouse,
(b)	the patient’s de facto partner,
(c)	a person with whom the patient is or was in a sexual relationship.

(3) This clause ceases to have effect on 1 January 2018.